Results 81 to 90 of about 265 (112)
Zilebesiran: A Promising Antihypertensive Therapy Inhibiting Angiotensinogen Synthesis
Cardiology in ReviewSystemic hypertension is one of the most common noncommunicable diseases globally, with over one billion people affected. Despite the widespread use of numerous antihypertensive drugs, it is estimated that only a fifth of diagnosed patients achieve adequate blood pressure control.
Rida S, Khan, William H, Frishman
exaly +4 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Zilebesiran: A Novel RNA Interference Therapeutic for Hypertension
Cardiology in ReviewHypertension remains a leading modifiable risk factor for cardiovascular morbidity and mortality, yet blood pressure control rates are suboptimal, partly due to adherence challenges with daily medications. Zilebesiran is an investigational small interfering RNA therapy targeting hepatic angiotensinogen synthesis to achieve prolonged suppression of the ...
Darshilkumar Maheta
exaly +3 more sources
BEYOND THE DAILY PILL: ZILEBESIRAN, THE FUTURE OF BLOOD PRESSURE CONTROL?
International Journal of Drug Delivery Technology.
Shivaraj D R +5 more
openaire +2 more sources
Zilebesiran — pierwszy lek oparty na technologii siRNA w terapii nadciśnienia tętniczego
Choroby Serca i Naczyń, 2023 Arterial hypertension is the most common risk factor for cardiovascular diseases in the world. Over the last 30 years, the incidence of hypertension has doubled.
Stanisław Surma, Krzysztof Narkiewicz
core +4 more sources
La terapia genica dell’ipertensione arteriosa: focus su zilebesiran
Giornale Italiano di Cardiologia, 2023 Angeli F. +3 more
openaire +3 more sources
Zilebesiran Add-On Treatment for Inadequately Controlled Hypertension
JAMA - Journal of the American Medical AssociationTianyu Chen
exaly +3 more sources
Transforming Hypertension Treatment: Zilebesiran’s Possible Impact
Cardiovascular Drugs and TherapyMuhammad Owais, Arisha Akhtar
exaly +3 more sources
Zilebesiran Add-On Treatment for Inadequately Controlled Hypertension—Reply
JAMA - Journal of the American Medical AssociationManish Saxena, Akshay Desai
exaly +3 more sources
Tratamento com interferência de RNA: zilebesiran o medicamento do futuro
STUDIES IN HEALTH SCIENCES, 2023A hipertensão arterial é uma condição global prevalente que aumenta o risco de doenças cardiovasculares. Porém, apesar das opções terapêuticas disponíveis, muitos pacientes não alcançam as metas de pressão arterial recomendadas. Um dos mecanismos que desempenham um papel crítico na regulação da pressão arterial é o sistema renina-angiotensina ...
Arthur Vinicios Araújo De Souza +19 more
openaire +1 more source